on behalf of the NCI-Naples Breast Cancer Group

Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial

G. D'aiuto, G. Botti, N. Normanno, 2006, British Journal of Cancer.

A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours

D. Frappaz, G. Vassal, J. Robert, 2006, British Journal of Cancer.

Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group.

R. Paridaens, R. Sylvester, J. Jassem, 1998, British Journal of Cancer.

A phase II study of single-agent gefitinib as first-line therapy in patients with stage IV non-small-cell lung cancer

H. Saka, H. Taniguchi, T. Oishi, 2006, British Journal of Cancer.